Inhibrx Biosciences Statistics
Total Valuation
INBX has a market cap or net worth of $1.21 billion. The enterprise value is $1.17 billion.
Important Dates
The next estimated earnings date is Monday, March 16, 2026, after market close.
| Earnings Date | Mar 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INBX has 14.54 million shares outstanding. The number of shares has increased by 6.72% in one year.
| Current Share Class | 14.54M |
| Shares Outstanding | 14.54M |
| Shares Change (YoY) | +6.72% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 18.93% |
| Owned by Institutions (%) | 47.52% |
| Float | 7.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 865.35 |
| Forward PS | n/a |
| PB Ratio | 32.79 |
| P/TBV Ratio | 32.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 832.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.49, with a Debt / Equity ratio of 2.90.
| Current Ratio | 4.49 |
| Quick Ratio | 4.28 |
| Debt / Equity | 2.90 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -21.65 |
Financial Efficiency
Return on equity (ROE) is -144.07% and return on invested capital (ROIC) is -75.27%.
| Return on Equity (ROE) | -144.07% |
| Return on Assets (ROA) | -60.97% |
| Return on Invested Capital (ROIC) | -75.27% |
| Return on Capital Employed (ROCE) | -137.91% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $8,696 |
| Profits Per Employee | -$963,267 |
| Employee Count | 161 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 55.38 |
Taxes
In the past 12 months, INBX has paid $2,000 in taxes.
| Income Tax | 2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +561.11% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +561.11% |
| 50-Day Moving Average | 79.74 |
| 200-Day Moving Average | 43.03 |
| Relative Strength Index (RSI) | 56.60 |
| Average Volume (20 Days) | 191,118 |
Short Selling Information
The latest short interest is 1.65 million, so 11.35% of the outstanding shares have been sold short.
| Short Interest | 1.65M |
| Short Previous Month | 1.71M |
| Short % of Shares Out | 11.35% |
| Short % of Float | 20.98% |
| Short Ratio (days to cover) | 6.46 |
Income Statement
In the last 12 months, INBX had revenue of $1.40 million and -$155.09 million in losses. Loss per share was -$10.03.
| Revenue | 1.40M |
| Gross Profit | -145.55M |
| Operating Income | -195.13M |
| Pretax Income | -155.08M |
| Net Income | -155.09M |
| EBITDA | -192.52M |
| EBIT | -195.13M |
| Loss Per Share | -$10.03 |
Full Income StatementBalance Sheet
The company has $153.09 million in cash and $106.91 million in debt, with a net cash position of $46.18 million or $3.18 per share.
| Cash & Cash Equivalents | 153.09M |
| Total Debt | 106.91M |
| Net Cash | 46.18M |
| Net Cash Per Share | $3.18 |
| Equity (Book Value) | 36.83M |
| Book Value Per Share | 2.54 |
| Working Capital | 125.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$143.39 million and capital expenditures -$47,000, giving a free cash flow of -$143.44 million.
| Operating Cash Flow | -143.39M |
| Capital Expenditures | -47,000 |
| Free Cash Flow | -143.44M |
| FCF Per Share | -$9.86 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -13,937.86% |
| Pretax Margin | -11,077.43% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INBX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.72% |
| Shareholder Yield | -6.72% |
| Earnings Yield | -12.80% |
| FCF Yield | -11.84% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -51.15% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
INBX has an Altman Z-Score of -3.43 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.43 |
| Piotroski F-Score | 2 |
